skip to content

Clinical Trials

MainTitle

Retrospective Study of the Survival of Patients Suffering From Hiv-related Progressive Multifocal Leukoencephalopathy (LEMPMAR)

This study has been completed
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild


Information provided by (Responsible Party)
Fondation Ophtalmologique Adolphe de Rothschild
ClinicalTrials.gov Identifier
NCT02895581

First received: September 6, 2016
Last updated: September 6, 2016
Last Verified: September 2016
History of Changes
Purpose

Purpose

Retrospective medical chart review of HIV-infected patients diagnosed with progressive multifocal leukoencephalopathy

Condition
Progressive Multifocal Leukoencephalopathy

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective

Further study details as provided by Fondation Ophtalmologique Adolphe de Rothschild:

Primary Outcome Measures

  • Rankin score [ Time Frame: 12 months after diagnosis of leukoencephalopathy ]

Enrollment: 34
Study Start Date: January 2006
Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)

Eligibility

Eligibility

Ages Eligible for Study: 18 Years and older  
Sexes Eligible for Study: All  
Accepts Healthy Volunteers: No  
Sampling Method: Non-Probability Sample  

Study Population

HIV-infected patients diagnosed with progressive multifocal leukoencephalopathy

Criteria

Inclusion Criteria:

  • HIV infected patients
  • Diagnosed with progressive multifocal leukoencephalopathy
  • Minimal follow-up of one year OR patient deceased less than one year after diagnosis


Exclusion Criteria:
  • Loss of follow-up within 12 months after diagnosis

contacts and locations

Contacts and Locations

Choosing to participate in a study is an important personal decision.Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02895581

Sponsors and Collaborators

Fondation Ophtalmologique Adolphe de Rothschild
More Information

More Information


Responsible Party: Fondation Ophtalmologique Adolphe de Rothschild  
ClinicalTrials.gov Identifier: NCT02895581   History of Changes  
Other Study ID Numbers: NI_AMR_2015_1  
Study First Received: September 6, 2016  
Last Updated: September 6, 2016  

Additional relevant MeSH terms:
Leukoencephalopathies
Leukoencephalopathy, Progressive Multifocal

ClinicalTrials.gov processed this data on October 17, 2017
This information is provided by ClinicalTrials.gov.